vs
Datavault AI Inc.(DVLT)与STANDARD BIOTOOLS INC.(LAB)财务数据对比。点击上方公司名可切换其他公司
Datavault AI Inc.的季度营收约是STANDARD BIOTOOLS INC.的1.7倍($33.8M vs $19.6M),Datavault AI Inc.净利率更高(2.0% vs -177.4%,领先179.4%),Datavault AI Inc.同比增速更快(3649.6% vs -11.5%),Datavault AI Inc.自由现金流更多($-734.0K vs $-23.1M),过去两年Datavault AI Inc.的营收复合增速更高(1051.7% vs -12.2%)
Datavault AI Inc是一家人工智能科技企业,主打AI驱动的数据管理与集成解决方案,主要服务北美地区的企业客户,帮助客户整合分散数据资产,优化分析流程,加速机器学习模型的开发与落地。
Standard BioTools(原Fluidigm公司)是一家美国生命科学工具企业,主营流式细胞术与组织成像分析用质谱流式系统,以及配套的检测试剂盒与试剂,同时供应自动化基因组分析仪器、各类微流控芯片(又称集成流体电路)及配套试剂耗材,全系列产品及应用场景均可提供定制检测方案与相关服务。
DVLT vs LAB — 直观对比
营收规模更大
DVLT
是对方的1.7倍
$19.6M
营收增速更快
DVLT
高出3661.0%
-11.5%
净利率更高
DVLT
高出179.4%
-177.4%
自由现金流更多
DVLT
多$22.4M
$-23.1M
两年增速更快
DVLT
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $33.8M | $19.6M |
| 净利润 | $661.0K | $-34.7M |
| 毛利率 | 89.3% | 48.5% |
| 营业利润率 | 12.3% | -168.5% |
| 净利率 | 2.0% | -177.4% |
| 营收同比 | 3649.6% | -11.5% |
| 净利润同比 | 110.4% | -28.8% |
| 每股收益(稀释后) | $0.53 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DVLT
LAB
| Q4 25 | $33.8M | — | ||
| Q3 25 | $2.9M | $19.6M | ||
| Q2 25 | $1.7M | $21.8M | ||
| Q1 25 | $629.0K | $40.8M | ||
| Q4 24 | $902.0K | — | ||
| Q3 24 | $1.2M | $22.1M | ||
| Q2 24 | $345.0K | $22.5M | ||
| Q1 24 | $255.0K | $45.5M |
净利润
DVLT
LAB
| Q4 25 | $661.0K | — | ||
| Q3 25 | $-33.0M | $-34.7M | ||
| Q2 25 | $-37.1M | $-33.5M | ||
| Q1 25 | $-9.6M | $-26.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-5.1M | $-26.9M | ||
| Q2 24 | $-42.7M | $-45.7M | ||
| Q1 24 | $2.7M | $-32.2M |
毛利率
DVLT
LAB
| Q4 25 | 89.3% | — | ||
| Q3 25 | 3.3% | 48.5% | ||
| Q2 25 | 2.0% | 48.8% | ||
| Q1 25 | 11.0% | 48.4% | ||
| Q4 24 | 24.6% | — | ||
| Q3 24 | 19.3% | 54.9% | ||
| Q2 24 | 3.2% | 46.1% | ||
| Q1 24 | — | 53.1% |
营业利润率
DVLT
LAB
| Q4 25 | 12.3% | — | ||
| Q3 25 | -508.1% | -168.5% | ||
| Q2 25 | -718.1% | -118.1% | ||
| Q1 25 | -1499.4% | -80.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | -447.4% | -120.9% | ||
| Q2 24 | -1566.7% | -134.5% | ||
| Q1 24 | -1630.6% | -132.2% |
净利率
DVLT
LAB
| Q4 25 | 2.0% | — | ||
| Q3 25 | -1135.5% | -177.4% | ||
| Q2 25 | -2139.3% | -153.7% | ||
| Q1 25 | -1520.3% | -63.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | -434.5% | -122.0% | ||
| Q2 24 | -12366.7% | -203.3% | ||
| Q1 24 | 1061.6% | -70.6% |
每股收益(稀释后)
DVLT
LAB
| Q4 25 | $0.53 | — | ||
| Q3 25 | $-0.33 | $-0.09 | ||
| Q2 25 | $-0.54 | $-0.09 | ||
| Q1 25 | $-0.18 | $-0.07 | ||
| Q4 24 | — | — | ||
| Q3 24 | $-1.39 | $-0.07 | ||
| Q2 24 | $-11.89 | $-0.12 | ||
| Q1 24 | $-5.35 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $2.0M | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $238.0M | $399.7M |
| 总资产 | $274.7M | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
DVLT
LAB
| Q4 25 | $2.0M | — | ||
| Q3 25 | $1.7M | $129.4M | ||
| Q2 25 | $662.0K | $158.6M | ||
| Q1 25 | $171.0K | $150.9M | ||
| Q4 24 | $3.3M | — | ||
| Q3 24 | $3.9M | $210.6M | ||
| Q2 24 | $6.1M | $269.8M | ||
| Q1 24 | $2.8M | $287.1M |
总债务
DVLT
LAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
股东权益
DVLT
LAB
| Q4 25 | $238.0M | — | ||
| Q3 25 | $99.5M | $399.7M | ||
| Q2 25 | $74.1M | $424.5M | ||
| Q1 25 | $81.7M | $454.6M | ||
| Q4 24 | $85.7M | — | ||
| Q3 24 | $4.3M | $489.3M | ||
| Q2 24 | $6.4M | $510.3M | ||
| Q1 24 | $-2.7M | $577.3M |
总资产
DVLT
LAB
| Q4 25 | $274.7M | — | ||
| Q3 25 | $138.7M | $539.6M | ||
| Q2 25 | $120.7M | $557.0M | ||
| Q1 25 | $95.7M | $579.6M | ||
| Q4 24 | $100.6M | — | ||
| Q3 24 | $8.0M | $681.5M | ||
| Q2 24 | $10.6M | $708.7M | ||
| Q1 24 | $6.9M | $777.7M |
负债/权益比
DVLT
LAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-406.0K | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $-734.0K | $-23.1M |
| 自由现金流率自由现金流/营收 | -2.2% | -118.1% |
| 资本支出强度资本支出/营收 | 1.0% | 4.5% |
| 现金转化率经营现金流/净利润 | -0.61× | — |
| 过去12个月自由现金流最近4个季度 | — | $-111.1M |
8季度趋势,按日历期对齐
经营现金流
DVLT
LAB
| Q4 25 | $-406.0K | — | ||
| Q3 25 | $-10.4M | $-22.2M | ||
| Q2 25 | $-6.8M | $-20.7M | ||
| Q1 25 | $-6.0M | $-30.3M | ||
| Q4 24 | $-17.5M | — | ||
| Q3 24 | $-4.2M | $-27.9M | ||
| Q2 24 | $-5.5M | $-39.0M | ||
| Q1 24 | $-3.5M | $-62.5M |
自由现金流
DVLT
LAB
| Q4 25 | $-734.0K | — | ||
| Q3 25 | — | $-23.1M | ||
| Q2 25 | — | $-22.6M | ||
| Q1 25 | $-6.1M | $-35.3M | ||
| Q4 24 | $-17.6M | — | ||
| Q3 24 | $-4.2M | $-30.1M | ||
| Q2 24 | $-5.5M | $-41.0M | ||
| Q1 24 | $-3.5M | $-63.3M |
自由现金流率
DVLT
LAB
| Q4 25 | -2.2% | — | ||
| Q3 25 | — | -118.1% | ||
| Q2 25 | — | -103.6% | ||
| Q1 25 | -966.0% | -86.6% | ||
| Q4 24 | -1946.9% | — | ||
| Q3 24 | -361.7% | -136.4% | ||
| Q2 24 | -1599.7% | -182.2% | ||
| Q1 24 | -1390.6% | -138.9% |
资本支出强度
DVLT
LAB
| Q4 25 | 1.0% | — | ||
| Q3 25 | 0.0% | 4.5% | ||
| Q2 25 | 0.0% | 8.7% | ||
| Q1 25 | 8.3% | 12.4% | ||
| Q4 24 | 3.9% | — | ||
| Q3 24 | 0.7% | 10.2% | ||
| Q2 24 | 4.1% | 8.6% | ||
| Q1 24 | 2.4% | 1.7% |
现金转化率
DVLT
LAB
| Q4 25 | -0.61× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -1.31× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DVLT
| Eos Technology Holdings Inc. | $30.0M | 89% |
| Consumer Audio Products Components And Other Revenue Net | $3.2M | 9% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |